HLA-A and ovarian carcinoma: In another study, neoantigen-reactive T cell lines expanded for seven different HLA class I-restricted neoepitopes from PB of an ovarian cancer patient, but only one recognized an HLA-A*02:01-restricted neoepitope [37].